Obstructive sleep apnea affects 1 billion people worldwide. CPAP therapy is the gold standard, but many struggle with it. Discover effective alternatives like oral appliances, positional therapy, and lifestyle changes that actually work.
Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs. The FDA requires bioequivalence, strict manufacturing controls, and stability testing to ensure generics work just as well-without the high price.
Opioid therapy can relieve severe pain, but it carries serious risks of dependence and overdose. Learn when it’s appropriate, how to spot danger signs, and what alternatives exist under current medical guidelines.
Constipation, drowsiness, and nausea are the most common side effects of opioid pain medications. Learn why they happen, how to manage them effectively, and why ignoring them can lead to dangerous outcomes.
States are using Preferred Drug Lists, copay differentials, and pharmacist substitution rules to push patients toward cheaper generic drugs. These policies save billions - but sustainability challenges loom as rebate systems threaten generic availability.
Pharmacokinetic studies are the backbone of generic drug approval, proving that generics behave like brand-name drugs in the body. But they're not perfect-especially for complex formulations. Here's how they work, where they fall short, and what's changing.
Pharmacists must stay current on generics to ensure safe substitutions, comply with state laws, and avoid malpractice. Learn the latest FDA requirements, ACPE standards, and practical CE strategies for 2026.
Learn how to use CGM trend arrows to adjust diabetes medication doses safely and prevent dangerous highs and lows. Proven methods from the Endocrine Society help you act before glucose crashes or spikes.
Learn how Medicare Part D formularies cover generic drugs in 2025, including cost tiers, the $2,000 out-of-pocket cap, how to save money, and what's changing next year.
Biosimilars work just as well as original biologics for cancer, arthritis, and autoimmune diseases. Learn how clinical data, real-world outcomes, and cost savings support their use-and why adoption still faces barriers.
